Benzinga's Top #PreMarket Gainers

By: via Benzinga
KaloBios Pharmaceuticals Inc (NASDAQ: KBIO) shares climbed 21.25 percent to $35.55 in pre-market trading. On Thursday, KaloBios ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.